Myndshroom stands as Awshad’s flagship product for 2024, embodying Awshad’s commitment to excellence and wellness
Awshad, a pioneering medical cannabis wellness startup, is thrilled to announce the launch of its latest innovation, Myndshroom. Representing the company’s debut in the nutraceutical category, Myndshroom is poised to revolutionise brain health and function with its unique blend of potent ingredients.
Myndshroom stands as Awshad’s flagship product for 2024, embodying Awshad’s commitment to excellence and wellness. Crafted as a premium non-prescription health supplement, Myndshroom is meticulously formulated with a blend of functional mushrooms including Lion’s Mane and Cordyceps, alongside the renowned L-theanine, delivering a powerful boost to cognitive function and mental clarity
Myndshroom is specifically designed to cater to a diverse audience, including students seeking improved focus, high-functioning executives navigating demanding workloads, athletes aiming for peak performance, and individuals at high risk of cognitive decline such as Alzheimer’s and dementia. Additionally, Myndshroom appeals to the burgeoning community of functional mushroom enthusiasts, offering a convenient and effective means of incorporating these superfoods into their daily routine.